Monoclonal antibodies Biosimilars Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market by Application
1.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Perspective (2018-2032)
2.2 Monoclonal antibodies (mAbs) Biosimilars Growth Trends by Region
2.2.1 Monoclonal antibodies (mAbs) Biosimilars Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Region (2018-2023)
2.2.3 Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Region (2023-2032)
2.3 Monoclonal antibodies (mAbs) Biosimilars Market Dynamics
2.3.1 Monoclonal antibodies (mAbs) Biosimilars Industry Trends
2.3.2 Monoclonal antibodies (mAbs) Biosimilars Market Drivers
2.3.3 Monoclonal antibodies (mAbs) Biosimilars Market Challenges
2.3.4 Monoclonal antibodies (mAbs) Biosimilars Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue
3.1.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue (2018-2023)
3.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Players (2018-2023)
3.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal antibodies (mAbs) Biosimilars Revenue
3.4 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio
3.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2022
3.5 Monoclonal antibodies (mAbs) Biosimilars Key Players Head office and Area Served
3.6 Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
3.7 Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Type
4.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Type (2018-2023)
4.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2023-2032)
5 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Application
5.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Application (2018-2023)
5.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2032)
6.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023)
6.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2032)
7.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023)
7.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2032)
8.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023)
8.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2032)
9.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023)
9.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2032)
10.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023)
10.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Biocon
11.1.1 Biocon Company Detail
11.1.2 Biocon Business Overview
11.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Introduction
11.1.4 Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
11.1.5 Biocon Recent Development
11.2 Celltrion
11.2.1 Celltrion Company Detail
11.2.2 Celltrion Business Overview
11.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Introduction
11.2.4 Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
11.2.5 Celltrion Recent Development
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Detail
11.3.2 Dr. Reddy's Laboratories Business Overview
11.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Introduction
11.3.4 Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
11.3.5 Dr. Reddy's Laboratories Recent Development
11.4 Hospira
11.4.1 Hospira Company Detail
11.4.2 Hospira Business Overview
11.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Introduction
11.4.4 Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
11.4.5 Hospira Recent Development
11.5 3SBio
11.5.1 3SBio Company Detail
11.5.2 3SBio Business Overview
11.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Introduction
11.5.4 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
11.5.5 3SBio Recent Development
11.6 Accord Healthcare
11.6.1 Accord Healthcare Company Detail
11.6.2 Accord Healthcare Business Overview
11.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Introduction
11.6.4 Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
11.6.5 Accord Healthcare Recent Development
11.7 AET Biotech
11.7.1 AET Biotech Company Detail
11.7.2 AET Biotech Business Overview
11.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
11.7.4 AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
11.7.5 AET Biotech Recent Development
11.8 Allergan
11.8.1 Allergan Company Detail
11.8.2 Allergan Business Overview
11.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Introduction
11.8.4 Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
11.8.5 Allergan Recent Development
11.9 Amega Biotech
11.9.1 Amega Biotech Company Detail
11.9.2 Amega Biotech Business Overview
11.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
11.9.4 Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
11.9.5 Amega Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Erythropoietin (EPO)
Table 3. Key Players of Human Growth Hormone (HGH)
Table 4. Key Players of Granulocyte- Colony Stimulating Factor (G-CSF)
Table 5. Key Players of Monoclonal Antibody (mAb)
Table 6. Key Players of Insulin
Table 7. Key Players of Interferon (IFN)
Table 8. Key Players of Others
Table 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 10. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 11. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2018-2023)
Table 13. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2023-2032)
Table 15. Monoclonal antibodies (mAbs) Biosimilars Market Trends
Table 16. Monoclonal antibodies (mAbs) Biosimilars Market Drivers
Table 17. Monoclonal antibodies (mAbs) Biosimilars Market Challenges
Table 18. Monoclonal antibodies (mAbs) Biosimilars Market Restraints
Table 19. Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players (2018-2023)
Table 21. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2022)
Table 22. Ranking of Global Top Monoclonal antibodies (mAbs) Biosimilars Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
Table 26. Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2018-2023)
Table 30. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 31. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2023-2032)
Table 32. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Application (2018-2023)
Table 34. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 35. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Application (2023-2032)
Table 36. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2032) & (US$ Million)
Table 38. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2032) & (US$ Million)
Table 40. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2023-2032) & (US$ Million)
Table 42. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2032) & (US$ Million)
Table 44. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2032) & (US$ Million)
Table 46. Biocon Company Detail
Table 47. Biocon Business Overview
Table 48. Biocon Monoclonal antibodies (mAbs) Biosimilars Product
Table 49. Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
Table 50. Biocon Recent Development
Table 51. Celltrion Company Detail
Table 52. Celltrion Business Overview
Table 53. Celltrion Monoclonal antibodies (mAbs) Biosimilars Product
Table 54. Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
Table 55. Celltrion Recent Development
Table 56. Dr. Reddy's Laboratories Company Detail
Table 57. Dr. Reddy's Laboratories Business Overview
Table 58. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Product
Table 59. Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
Table 60. Dr. Reddy's Laboratories Recent Development
Table 61. Hospira Company Detail
Table 62. Hospira Business Overview
Table 63. Hospira Monoclonal antibodies (mAbs) Biosimilars Product
Table 64. Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
Table 65. Hospira Recent Development
Table 66. 3SBio Company Detail
Table 67. 3SBio Business Overview
Table 68. 3SBio Monoclonal antibodies (mAbs) Biosimilars Product
Table 69. 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
Table 70. 3SBio Recent Development
Table 71. Accord Healthcare Company Detail
Table 72. Accord Healthcare Business Overview
Table 73. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Product
Table 74. Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
Table 75. Accord Healthcare Recent Development
Table 76. AET Biotech Company Detail
Table 77. AET Biotech Business Overview
Table 78. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Product
Table 79. AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
Table 80. AET Biotech Recent Development
Table 81. Allergan Company Detail
Table 82. Allergan Business Overview
Table 83. Allergan Monoclonal antibodies (mAbs) Biosimilars Product
Table 84. Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
Table 85. Allergan Recent Development
Table 86. Amega Biotech Company Detail
Table 87. Amega Biotech Business Overview
Table 88. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Product
Table 89. Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
Table 90. Amega Biotech Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Type: 2022 VS 2032
Figure 2. Erythropoietin (EPO) Features
Figure 3. Human Growth Hormone (HGH) Features
Figure 4. Granulocyte- Colony Stimulating Factor (G-CSF) Features
Figure 5. Monoclonal Antibody (mAb) Features
Figure 6. Insulin Features
Figure 7. Interferon (IFN) Features
Figure 8. Others Features
Figure 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application in 2022 & 2032
Figure 10. Anti-Cancer Case Studies
Figure 11. Anti-Inflammatory/Autoimmune Case Studies
Figure 12. Monoclonal antibodies (mAbs) Biosimilars Report Years Considered
Figure 13. Global Monoclonal antibodies (mAbs) Biosimilars Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Region: 2022 VS 2032
Figure 16. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players in 2022
Figure 17. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2022
Figure 19. North America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2018-2032)
Figure 21. United States Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. Canada Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2018-2032)
Figure 25. Germany Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. France Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. U.K. Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Italy Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Russia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2018-2032)
Figure 33. China Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. South Korea Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. India Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Australia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2018-2032)
Figure 41. Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2018-2032)
Figure 45. Turkey Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 46. Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 47. Biocon Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
Figure 48. Celltrion Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
Figure 49. Dr. Reddy's Laboratories Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
Figure 50. Hospira Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
Figure 51. 3SBio Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
Figure 52. Accord Healthcare Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
Figure 53. AET Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
Figure 54. Allergan Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
Figure 55. Amega Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Industry Market Size
